Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
![Insider Trading Transactions for Entrada Therapeutics Inc.](/ichart-1689375-930-180-60.png)
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-07-12 Sale | 2024-07-16 4:43 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 1,238 | $18 | $22,284 | 188,814 (Direct) | View |
2024-07-12 Sale | 2024-07-16 4:42 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,900 | $17.84 | $33,897 | 334,475 (Direct) | View |
2024-07-08 Sale | 2024-07-10 4:34 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,758 | $14.95 | $26,282 | 81,412 (Direct) | View |
2024-06-13 Sale | 2024-06-14 4:32 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,000 | $16.17 | $16,174 | 336,375 (Direct) | View |
2024-05-16 Sale | 2024-05-20 5:26 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 18,980 | $15.16 | $287,695 | 190,052 (Direct) | View |
2024-05-16 Sale | 2024-05-20 5:21 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 3,000 | $15.04 | $45,129 | 337,375 (Direct) | View |
2024-05-14 Purchase | 2024-05-16 4:33 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 25,000 | $14.59 | $364,673 | 92,412 (Direct) | View |
2024-05-08 Purchase | 2024-05-10 4:35 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 4,476 | $14.14 | $63,306 | 67,412 (Direct) | View |
2024-04-08 Purchase | 2024-04-10 4:35 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 2,600 | $13.57 | $35,290 | 62,936 (Direct) | View |
2024-03-28 Purchase | 2024-04-01 4:31 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 1,512 | $13.75 | $20,794 | 60,336 (Direct) | View |
2024-03-22 Purchase | 2024-03-26 5:57 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 9,048 | $13.58 | $122,882 | 58,824 (Direct) | View |
2024-03-19 Purchase | 2024-03-21 4:31 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 2,732 | $12.81 | $34,996 | 49,776 (Direct) | View |
2024-03-06 Sale | 2024-03-08 4:36 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,086 | $12.31 | $50,285 | 74,170 (Direct) | View |
2024-03-06 Sale | 2024-03-08 4:34 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 1,826 | $12.32 | $22,499 | 137,204 (Direct) | View |
2024-02-15 Sale | 2024-02-20 4:37 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,000 | $15 | $15,000 | 243,279 (Direct) | View |
2024-01-16 Sale | 2024-01-18 4:32 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,000 | $15.99 | $15,990 | 244,279 (Direct) | View |
2023-12-21 Sale | 2023-12-26 4:35 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 12,500 | $15.59 | $194,845 | 216,436 (Direct) | View |
2023-12-20 Sale | 2023-12-22 4:38 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,000 | $15 | $15,000 | 245,279 (Direct) | View |
2023-11-13 Sale | 2023-11-13 4:35 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,000 | $16.23 | $16,230 | 246,279 (Direct) | View |
2023-10-17 Sale | 2023-10-19 5:27 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,000 | $15 | $15,000 | 247,279 (Direct) | View |
2023-09-13 Sale | 2023-09-15 4:21 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,000 | $15 | $15,000 | 248,279 (Direct) | View |
2023-09-06 Sale | 2023-09-06 5:11 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 950 | $13.48 | $12,806 | 71,071 (Direct) | View |
2023-09-06 Sale | 2023-09-06 5:08 pm | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 892 | $13.48 | $12,022 | 61,537 (Direct) | View |
2023-09-06 Sale | 2023-09-06 5:07 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 972 | $13.47 | $13,089 | 69,668 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-13 Option Award | 2024-06-14 4:39 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
2024-06-13 Option Award | 2024-06-14 4:38 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 16,000 | $0 | 16,000 (Direct) | View |
2024-06-13 Option Award | 2024-06-14 4:36 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | Thistle Mary Director | 16,000 | $0 | 16,000 (Direct) | View |
2024-06-13 Option Award | 2024-06-14 4:34 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | Zeiher Bernhardt G Director | 16,000 | $0 | 16,000 (Direct) | View |
2024-06-13 Option Award | 2024-06-14 4:33 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | Chapman Gina Director | 16,000 | $0 | 16,000 (Direct) | View |
2024-06-03 Exercise | 2024-06-05 4:31 pm | N/A 2032-06-02 | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 11,918 | $0 | 104,330 (Direct) | View |
2024-06-03 Exercise | 2024-06-05 4:31 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 11,918 | $6.06 | 104,330 (Direct) | View |
2024-03-15 Exercise | 2024-03-19 4:33 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 9,000 | $0 | 126,327 (Direct) | View |
2024-03-15 Exercise | 2024-03-19 4:33 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 9,000 | $2.1 | 126,327 (Direct) | View |
2024-03-05 Tax Withholding | 2024-03-05 7:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 5,049 | $12.28 | 498,875 (Direct) | View |
2024-03-04 Tax Withholding | 2024-03-05 7:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,391 | $13.37 | 498,875 (Direct) | View |
2024-03-04 Tax Withholding | 2024-03-05 7:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,164 | $12.42 | 498,875 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:48 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 263,200 | $0 | 498,875 (Direct) | View |
2024-03-05 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,471 | $12.28 | 125,056 (Direct) | View |
2024-03-04 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 405 | $13.37 | 125,056 (Direct) | View |
2024-03-04 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 339 | $12.42 | 125,056 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:47 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 77,700 | $0 | 125,056 (Direct) | View |
2024-03-05 Tax Withholding | 2024-03-05 7:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 1,486 | $12.28 | 189,130 (Direct) | View |
2024-03-04 Tax Withholding | 2024-03-05 7:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 409 | $13.37 | 189,130 (Direct) | View |
2024-03-04 Tax Withholding | 2024-03-05 7:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 343 | $12.42 | 189,130 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:46 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 143,200 | $0 | 189,130 (Direct) | View |
2024-03-05 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 1,505 | $12.28 | 275,832 (Direct) | View |
2024-03-04 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 414 | $13.37 | 275,832 (Direct) | View |
2024-03-04 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 347 | $12.42 | 275,832 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:44 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 110,900 | $0 | 275,832 (Direct) | View |
2023-12-21 Exercise | 2023-12-26 4:35 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 12,500 | $0 | 216,436 (Direct) | View |
2023-12-21 Exercise | 2023-12-26 4:35 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 12,500 | $2.1 | 216,436 (Direct) | View |
2023-09-05 Tax Withholding | 2023-09-06 5:12 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 1,440 | $14.46 | 324,529 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 5:12 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | Doshi Dipal President and CEO | 124,900 | $0 | 324,529 (Direct) | View |
2023-09-05 Tax Withholding | 2023-09-06 5:11 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 426 | $14.46 | 71,071 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 5:11 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 35,700 | $0 | 71,071 (Direct) | View |
2023-09-05 Tax Withholding | 2023-09-06 5:09 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 449 | $14.46 | 188,698 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 5:09 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 35,700 | $0 | 188,698 (Direct) | View |
2023-09-05 Tax Withholding | 2023-09-06 5:08 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 401 | $14.46 | 61,537 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 5:08 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | KREHER NERISSA Chief Medical Officer | 35,700 | $0 | 61,537 (Direct) | View |
2023-09-05 Tax Withholding | 2023-09-06 5:07 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 436 | $14.46 | 69,668 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 5:07 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 35,700 | $0 | 69,668 (Direct) | View |
2023-09-01 Option Award | 2023-09-05 4:31 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | Chapman Gina Director | 32,000 | $0 | 32,000 (Direct) | View |